World's Best Scientists 2026 revealed!
Sabine Tejpar

Sabine Tejpar

D-Index & Metrics

Medicine

D-Index
93
Citations
52724
World Ranking
10662
National Ranking
126

Overview

Sabine Tejpar is affiliated with KU Leuven in Belgium and has a significant research footprint primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans various subfields including Oncology, Molecular Biology, Cancer Research, Immunology, and Pathology and Forensic Medicine.

Key areas of focus in their research include:

  • Genetic factors in colorectal cancer
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Colorectal Cancer Treatments and Studies
  • Immune Cell Function and Interaction
  • Pancreatic and Hepatic Oncology Research
  • Single-cell and spatial transcriptomics

The scientist has contributed multiple papers to notable journals with research spanning from 2020 to 2022. Significant recent publications include:

  • Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer, 2020, Nature Genetics
  • A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling, 2020, Cell Research
  • Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer, 2022, Nature Genetics
  • Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages, 2021, Cell Research
  • Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity, 2021, Nature Communications

Frequent publication venues include bioRxiv (Cold Spring Harbor Laboratory), Journal of Clinical Oncology, Annals of Oncology, Nature Communications, and Nature Genetics, reflecting a broad dissemination of research in oncology and related fields.

Sabine Tejpar has collaborated extensively with other researchers, with frequent coauthors including Abhishek D. Garg, Diether Lambrechts, Sara Verbandt, Jenny Sprooten, and Yourae Hong. These collaborations highlight a network of expertise supporting their multidisciplinary research efforts.

Best Publications

  • Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer.

    Eric Van Cutsem;Claus Henning Köhne;Erika Hitre;Jerzy Zaluski

  • The consensus molecular subtypes of colorectal cancer

    Justin Guinney;Rodrigo Dienstmann;Rodrigo Dienstmann;Xingwu Wang;Xingwu Wang;Aurélien De Reyniès

  • ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    E. Van Cutsem;A. Cervantes;R. Adam;A. Sobrero

  • Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis

    Wendy De Roock;Bart Claes;David Bernasconi;Jef De Schutter

  • Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status

    Eric Van Cutsem;Claus Henning Köhne;István Láng;Gunnar Folprecht

  • KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

    W. De Roock;H. Piessevaux;J. De Schutter;M. Janssens

  • Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

    Arnaud D. Roth;Sabine Tejpar;Mauro Delorenzi;Pu Yan

  • Peutz–Jeghers syndrome: a systematic review and recommendations for management

    A. D. Beggs;A. R. Latchford;H. F. A. Vasen;G. Moslein

  • Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer

    Rodrigo Dienstmann;Louis Vermeulen;Justin Guinney;Scott Kopetz

  • Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancer

    Eric Van Cutsem;Heinz Josef Lenz;Claus Henning Köhne;Volker Heinemann

  • Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab

    Wendy De Roock;Derek J Jonker;Federica Di Nicolantonio;Andrea Sartore-Bianchi

  • Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

    Hans F A Vasen;Ignacio Blanco;Katja Aktan-Collan;Jessica P Gopie

  • A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4).

    Carol J Gallione;Gabriela M Repetto;Eric Legius;Anil K Rustgi

  • Guidelines for the clinical management of familial adenomatous polyposis (FAP)

    H. F. A Vasen;G. Moslein;A. Alonso;S. Aretz

  • Prognostic and Predictive Relevance of Primary Tumor Location in Patients With RAS Wild-Type Metastatic Colorectal Cancer Retrospective Analyses of the CRYSTAL and FIRE-3 Trials

    Sabine Tejpar;Sebastian Stintzing;Fortunato Ciardiello;Josep Tabernero

  • KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer

    Wendy De Roock;Veerle De Vriendt;Nicola Normanno;Fortunato Ciardiello

  • Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features.

    E. Missiaglia;B. Jacobs;G. D'Ario;A.F. Di Narzo

  • Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus.

    René Adam;Aimery de Gramont;Joan Figueras;Norihiro Kokudo

  • KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience

    E. Van Cutsem;I. Lang;G. D'haens;V. Moiseyenko

  • A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling.

    Junbin Qian;Siel Olbrecht;Bram Boeckx;Hanne Vos

Frequent Co-Authors

Mauro Delorenzi
Mauro Delorenzi University of Lausanne
Fortunato Ciardiello
Fortunato Ciardiello University of Campania "Luigi Vanvitelli"
Fred T. Bosman
Fred T. Bosman University of Lausanne
Bart Jacobs
Bart Jacobs Radboud University
Josep Tabernero
Josep Tabernero Vall d´Hebron Institute of Oncology
Pierre Laurent-Puig
Pierre Laurent-Puig Université Paris Cité
Heinz-Josef Lenz
Heinz-Josef Lenz University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always follow the traditional medical degree route. There are a variety of rn to bsn online no clinicals accredited programs available, making it possible for working registered nurses to advance their credentials without required hands-on clinical components.

For those interested in doctoral-level nursing, flexibility and speed matter. Consider the options for the fastest online dnp programs to quickly complete your Doctor of Nursing Practice while balancing career and personal commitments.

Academic rigor in doctoral programs can also be managed through dnp programs without dissertation, which streamline graduation requirements by eliminating the traditional dissertation project.

Aspiring nurses eager to enter the workforce rapidly should explore fast track lpn programs online. These programs offer accelerated pathways to becoming a Licensed Practical Nurse, supporting quicker entry into healthcare roles.

Each pathway offers unique opportunities for career advancement in medicine, catering to diverse learning styles, career goals, and time constraints. Carefully compare your options to find the best fit for your aspirations.

Best Scientists Citing Sabine Tejpar

Trending Scientists

Recently Published Articles